965 related articles for article (PubMed ID: 32767055)
1. Challenges and management of neurological and psychiatric manifestations in SARS-CoV-2 (COVID-19) patients.
Orsini A; Corsi M; Santangelo A; Riva A; Peroni D; Foiadelli T; Savasta S; Striano P
Neurol Sci; 2020 Sep; 41(9):2353-2366. PubMed ID: 32767055
[TBL] [Abstract][Full Text] [Related]
2. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms.
Zhou Z; Kang H; Li S; Zhao X
J Neurol; 2020 Aug; 267(8):2179-2184. PubMed ID: 32458193
[TBL] [Abstract][Full Text] [Related]
3. The Spectrum of Neurologic Disease in the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic Infection: Neurologists Move to the Frontlines.
Pleasure SJ; Green AJ; Josephson SA
JAMA Neurol; 2020 Jun; 77(6):679-680. PubMed ID: 32275291
[No Abstract] [Full Text] [Related]
4. Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review.
Zubair AS; McAlpine LS; Gardin T; Farhadian S; Kuruvilla DE; Spudich S
JAMA Neurol; 2020 Aug; 77(8):1018-1027. PubMed ID: 32469387
[TBL] [Abstract][Full Text] [Related]
5. Neurological manifestations in coronavirus disease 2019.
Corona T; Rodríguez-Violante M; Delgado-García G
Gac Med Mex; 2020; 156(4):317-320. PubMed ID: 32831319
[TBL] [Abstract][Full Text] [Related]
6. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China.
Mao L; Jin H; Wang M; Hu Y; Chen S; He Q; Chang J; Hong C; Zhou Y; Wang D; Miao X; Li Y; Hu B
JAMA Neurol; 2020 Jun; 77(6):683-690. PubMed ID: 32275288
[TBL] [Abstract][Full Text] [Related]
7. An Italian multicenter retrospective-prospective observational study on neurological manifestations of COVID-19 (NEUROCOVID).
Ferrarese C; Silani V; Priori A; Galimberti S; Agostoni E; Monaco S; Padovani A; Tedeschi G;
Neurol Sci; 2020 Jun; 41(6):1355-1359. PubMed ID: 32430621
[TBL] [Abstract][Full Text] [Related]
8. European Society of Minimally Invasive Neurological Therapy (ESMINT) recommendations for optimal interventional neurovascular management in the COVID-19 era.
Aggour M; White P; Kulcsar Z; Fiehler J; Brouwer P
J Neurointerv Surg; 2020 Jun; 12(6):542-544. PubMed ID: 32303584
[No Abstract] [Full Text] [Related]
9. Neurological manifestations of COVID-19: a review of what we know so far.
Gklinos P
J Neurol; 2020 Sep; 267(9):2485-2489. PubMed ID: 32458197
[TBL] [Abstract][Full Text] [Related]
10. Neurological associations of COVID-19.
Ellul MA; Benjamin L; Singh B; Lant S; Michael BD; Easton A; Kneen R; Defres S; Sejvar J; Solomon T
Lancet Neurol; 2020 Sep; 19(9):767-783. PubMed ID: 32622375
[TBL] [Abstract][Full Text] [Related]
11. Environmental Issues and Neurological Manifestations Associated with COVID-19 Pandemic: New Aspects of the Disease?
Bellocchio L; Bordea IR; Ballini A; Lorusso F; Hazballa D; Isacco CG; Malcangi G; Inchingolo AD; Dipalma G; Inchingolo F; Piscitelli P; Logroscino G; Miani A
Int J Environ Res Public Health; 2020 Nov; 17(21):. PubMed ID: 33139595
[TBL] [Abstract][Full Text] [Related]
12. Lifting the mask on neurological manifestations of COVID-19.
Pezzini A; Padovani A
Nat Rev Neurol; 2020 Nov; 16(11):636-644. PubMed ID: 32839585
[TBL] [Abstract][Full Text] [Related]
13. Temporal Correlation Between Neurological and Gastrointestinal Symptoms of SARS-CoV-2.
Bostancıklıoğlu M
Inflamm Bowel Dis; 2020 Jul; 26(8):e89-e91. PubMed ID: 32440692
[TBL] [Abstract][Full Text] [Related]
14. The Coronavirus Disease 2019 Crisis as Catalyst for Telemedicine for Chronic Neurological Disorders.
Bloem BR; Dorsey ER; Okun MS
JAMA Neurol; 2020 Aug; 77(8):927-928. PubMed ID: 32329796
[No Abstract] [Full Text] [Related]
15. Neurological manifestations and complications of COVID-19: A literature review.
Ahmad I; Rathore FA
J Clin Neurosci; 2020 Jul; 77():8-12. PubMed ID: 32409215
[TBL] [Abstract][Full Text] [Related]
16. Tele-health in neurology: an indispensable tool in the management of the SARS-CoV-2 epidemic.
Capra R; Mattioli F
J Neurol; 2020 Jul; 267(7):1885-1886. PubMed ID: 32399695
[No Abstract] [Full Text] [Related]
17. [COVID-19: A neurological point-of-view].
Simon OJ; Timmermann L
Dtsch Med Wochenschr; 2020 Jul; 145(15):1074-1079. PubMed ID: 32731282
[TBL] [Abstract][Full Text] [Related]
18. Neurological manifestations of COVID-19: A brief review.
Sachdev K; Agrawal S; Ish P; Gupta N; Raheja K
Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):41-47. PubMed ID: 32859864
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 and management of neuroimmunological disorders.
Hartung HP; Aktas O
Nat Rev Neurol; 2020 Jul; 16(7):347-348. PubMed ID: 32444648
[TBL] [Abstract][Full Text] [Related]
20. The "Three Italy" of the COVID-19 epidemic and the possible involvement of SARS-CoV-2 in triggering complications other than pneumonia.
Prezioso C; Marcocci ME; Palamara AT; De Chiara G; Pietropaolo V
J Neurovirol; 2020 Jun; 26(3):311-323. PubMed ID: 32548750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
